EU GMP Expansion Indoco has recently expanded facilities in Baddi and secured EU GMP certification for solid oral dosage and sterile facilities (Goa plant), signaling readiness to supply European markets and potentially larger contract manufacturing opportunities.

Global Reach & Partners With a broad global footprint, partnerships with Clarity Pharma and UK distribution, plus active US/EU regulatory compliance (IAS division USFDA approved), there are clear avenues for co-development, toll manufacturing, and sanctioned supply agreements in regulated markets.

Financial Recovery Recent Q4 FY26 profitability turnaround and positive earnings point to improved financial health and capacity for scaled sales deals, promotional programs, and longer-term supply contracts with risk-sharing structures.

Diverse Portfolio A wide-branded portfolio across Stomatologicals, GI, Respiratory, Anti-Infectives, vitamins, ophthalmics, and more, along with analgesics and anti-diabetic segments, offers cross-sell opportunities to existing distributor networks and new regional partners.

R&D & Innovation In-house R&D capabilities for non-infringing APIs, various dosage forms, and nano suspensions position Indoco to collaborate on specialized formulations, sterile injectables, and long-acting therapies for customized contract development and manufacturing.